-
ecDNA copy number heterogeneity
Study
EGAS50000000509
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Single cell RNA sequencing of relapsed/refractory multiple myeloma
Study
EGAS00001004805
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance (H067)
Study
EGAS00001004363
-
ENCORAFENIB COMBINED WITH BINIMETINIB FOR BRAFV600E-MUTATED RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE PHASE II GMMG-BIRMA TRIAL (Hipo_K08K)
Study
EGAS00001005973
-
Failure of Differentiation of the Rhombic Lip Constitutes Medulloblastoma
Study
EGAS00001005826
-
Single-cell multi-omics of relapse/refractory multiple myeloma patients (Hipo K08K/H067/K43R)
Study
EGAS00001006538
-
Whole-exome sequencing of HPV-negative HNSCC to identify pathway alterations
Study
EGAS50000001550
-
Multi-omics datasets (WES, RNA-seq) of mesothelioma MIST2 study, a phase II CDK4/6 (abemaciclib) clinical trial
Study
EGAS50000001823
-
Multi-omics datasets (WES, RNA-seq) of mesothelioma NERO study, a phase II PARP inhibitor clinical trial
Study
EGAS50000001825
-
Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)
Study
EGAS00001007469
-
Stratifying and Targeting Pediatric Medulloblastoma through Genomics
Study
EGAS00001000273
-
RNA sequencing dataset of of explants treated with PRX3 inhibitor thiostrepton in mesothelioma
Dataset
EGAD50000002650
-
Transcriptome profiling of HNSCC treated with PD1/PDL1
Dataset
EGAD50000002506
-
Whole genome sequencing of primary and metastatic Melanoma cases in an Australian cohort.
Study
EGAS00001001552
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Transcriptomic profiling of Hedgehog-high and Hedgehog-low HPV-negative HNSCC
Study
EGAS50000001549
-
Neuroblastoma and adrenal gland single-cell study
Study
EGAS00001004388
-
Anaplastic Large Cell Lymphoma Tumor Gene Expression Profiling
Study
EGAS50000001011
-
Anaplastic Large Cell Lymphoma Gene Expression
Dataset
EGAD50000001478
-
Mayo Anaplastic Large Cell Lymphoma Gene Expression
Dac
EGAC50000000633
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Study
EGAS00001003931
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH
Study
EGAS00001004285
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma
Study
EGAS00001005356
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Multi-organ landscape of therapy-resistant melanoma
Study
EGAS00001006644
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
NanoString nCounter® PanCancer IO 360™on anti-PD1/anti-PD1+CTLA4 in patients with metastatic melanoma
Study
EGAS00001006977
-
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma
Study
EGAS00001006986
-
An IL-1β driven neutrophil-stromal cell axis fosters a BAFF-rich microenvironment in multiple myeloma
Study
EGAS00001007038
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
GBM-Space: Joint Transcriptome and Chromatin Accessibility Profiling of Glioblastoma (10x Genomics - Multiome)
Dataset
EGAD00001015526
-
GBM-Space: Spatial Transcriptomic Profiling of Glioblastoma (10x Genomics - Visium)
Dataset
EGAD00001015527